FEMSelect has designed a minimally-invasive, meshless system for anchoring sutures to ligaments of the pelvic floor for uterine prolapse surgical procedures.
Location: United States, Delaware, Newark
Total raised: $9M
Investors 7
| Date | Name | Website |
| 09.07.2021 | Robin Hood... | robinhoodv... |
| 21.05.2021 | Mid Atlant... | bioangels.... |
| 18.10.2022 | Teal Ventu... | teal-ventu... |
| - | Triventure... | triventure... |
| - | New Age Ve... | newagevent... |
| - | New York A... | newyorkang... |
| - | RAD Biomed | radbiomed.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.10.2022 | Series B | $9M | TransPacif... |
Mentions in press and media 4
| Date | Title | Description |
| 22.10.2022 | Israel-based women’s health startup FEMSelect raises USD 9 million in Series B funding | TEL AVIV, Israel, Oct. 19, 2022— FEMSelect, the creator of EnPlace®, a minimally invasive, meshless approach to pelvic floor ligament fixation, announced today the completion of its USD 9 million Series B funding. Robin Hood Ventures, Mid A... |
| 20.10.2022 | FEMSelect Raises US$9M in Series B Financing | FemSelect, a Tel Aviv, Israel-based developer of an innovative approach to pelvic floor ligament fixation, raised US$9M in Series B funding. The round was led by New Age Ventures, and TriVentures, with participation from Robin Hood Ventures... |
| 20.10.2022 | FEMSelect raises $9M to expand its pelvic floor fixation device | The company will continue to expand in the US to enable more women to access its EnPlace device Pelvic organ prolapse (POP) occurs when the normal support of the vagina is lost, resulting in the “sagging” or dropping of the female pelvic or... |
| - | FEMSelect | “FEMSelect has designed a minimally-invasive, meshless system for anchoring sutures to ligaments of the pelvic floor for uterine prolapse surgical procedures.” |